Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 75

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 3
Chunk 75
---
 is our policy to
require our employees and contractors who may be involved in the conception or development of intellectual property to execute agreements
assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who, in fact, conceives
or develops intellectual property that we regard as our own. The assignment of intellectual property rights may not be self-executing,
or the assignment agreements may be breached, and we may be forced to bring claims against third parties, or defend claims that they may
bring against us, to determine the ownership of what we regard as our intellectual property. Such claims could have a material adverse
effect on our business, financial condition, results of operations, and prospects.

We may be subject to claims that our employees,
consultants or independent contractors have wrongfully used or disclosed confidential information or alleged trade secrets of third parties
or competitors or are in breach of non-competition or non-solicitation agreements with our competitors or their former employers.

We have received confidential
and proprietary information from third parties. In addition, as is common in the biotechnology, medical device and pharmaceutical industries,
we employ individuals and engage the services of consultants who were previously employed or engaged at other biotechnology or pharmaceutical
companies, including our competitors or potential competitors. Although no claims against us are currently pending, we may be subject
to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed confidential
information of these third parties or our employees’ former employers or our consultants’ or contractors’ current or
former clients or customers. In addition, we may in the future be subject to claims that we caused an employee to breach the terms of
his or her non-competition or non-solicitation agreement. Litigation may be necessary to defend against these claims. Even if we are successful
in defending against these claims, litigation could result in substantial cost and be a distraction to our management and employees. If
we are not successful, in addition to paying monetary damages, we could lose access or exclusive access to valuable intellectual property
rights or lose valuable personnel. Any litigation or the threat thereof may adversely affect our ability to hire employees. A loss of
key personnel or their work product could hamper or prevent our ability to commercialize product candidates, which could have an adverse
effect on our business, financial condition and results of operations.

If our trademarks and trade names are not
adequately protected, then we may not be able to build name recognition in our marks of